Affiliation:
1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama
Abstract
ABSTRACT
MICs were determined for an investigational ketolide, CEM-101, and azithromycin, telithromycin, doxycycline, levofloxacin, clindamycin, and linezolid against 36
Mycoplasma pneumoniae
, 5
Mycoplasma genitalium
, 13
Mycoplasma hominis
, 15
Mycoplasma fermentans
, and 20
Ureaplasma
isolates. All isolates, including two macrolide-resistant
M. pneumoniae
isolates, were inhibited by CEM-101 at ≤0.5 μg/ml, making CEM-101 the most potent compound tested.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献